You didn’t skip a meal, sleep poorly, or drink wine the night before, yet the migraine shows up anyway, pulsing behind one eye like it has somewhere to be. Migraines are a strongly heritable condition, with twin studies estimating genetic contribution at 34 to 57%, though diet, sleep, stress, and hormonal shifts all still play a real role in triggering individual attacks (Hussain et al., 2021). One of the more consistently studied genes is TRPM8, which builds a channel that senses cold and mechanical stimuli in trigeminal nerve fibers, the same nerve pathway heavily implicated in migraine pain. Genome-wide association studies have repeatedly linked variants near this gene to migraine susceptibility (Kanju et al., 2020). This is one piece among several, not a complete explanation for any individual’s migraines.
TRPM8 and the Original GWAS Discovery
Migraine’s genetic basis for common, everyday forms of the condition remained largely mysterious until genome-wide association studies began scanning the entire genome for patterns. Three loci emerged repeatedly: variants near TRPM8, near LRP1, and within PRDM16, a gene involved in tissue development.
Well-Replicated, but Not Universally Consistent
A meta-analysis of these three variants found that the TRPM8 and LRP1 associations had been independently replicated by additional genome-wide studies, lending real weight to the original findings (Rubino et al., 2022). At the same time, the same meta-analysis noted that follow-up candidate-gene studies testing these variants in smaller, specific populations have produced inconsistent results, with some finding significant associations and others finding none at all. A study in Pakistani migraine patients, for example, found a strong PRDM16 association but only a partial, allele-level signal for TRPM8 (Hussain et al., 2021). This pattern, strong in large discovery studies but variable in smaller replication attempts, is common in complex genetic conditions and doesn’t undermine the original finding so much as reflect how population size and genetic background can shift results.
What TRPM8 Might Actually Be Doing
Animal research offers a plausible mechanism: TRPM8 activation has been shown to increase susceptibility to cortical spreading depolarization, a wave of neuronal activity thought to underlie migraine aura, and to facilitate trigeminal nerve inflammation associated with migraine pain (Chen et al., 2025). This helps explain why a gene best known for sensing cold could plausibly be tangled up in headache biology.
CACNA1A: A Rare but Well-Understood Monogenic Cause
While TRPM8 and its neighbors involve small, cumulative effects across the general population, a small number of people have migraines driven by a single, much more powerful gene. CACNA1A encodes part of a neuronal calcium channel, and specific mutations in this gene cause familial hemiplegic migraine, a rare, severe subtype involving temporary weakness on one side of the body during attacks.
CACNA1A mutations account for roughly half of familial hemiplegic migraine cases and effectively all cases where the condition is also accompanied by cerebellar ataxia, a coordination disorder (Ducros et al., 2001). These mutations increase calcium flow into neurons, making them hyperexcitable and lowering the threshold for the same cortical spreading depolarization implicated in TRPM8 research above. This is a helpful illustration of how migraine genetics operates on two very different scales: common variants that nudge risk slightly across millions of people, and rare mutations that single-handedly cause a specific, severe subtype in a small number of families.
ESR1 and Estrogen: A Hypothesis That Hasn’t Held Up
Given that migraine affects women roughly three times more often than men, and that many women notice a clear link between attacks and their menstrual cycle, the estrogen receptor gene ESR1 seemed like an obvious genetic suspect. It’s worth being honest about how this has actually played out in research.
A comprehensive meta-analysis of 20 case-control studies examining three specific ESR1 variants found no significant association with migraine risk overall (Kumar et al., 2024). Separately, researchers have noted that genome-wide association studies, which are less prone to the biases that smaller candidate-gene studies carry, suggest the earlier reported ESR1-migraine link may be a false positive altogether (Sutherland et al., 2017). Some related genes, like SYNE1, which sits near ESR1 on the chromosome, have shown more promising associations with menstrual migraine specifically, suggesting the real hormonal genetic story, if there is one, may be more complicated than the estrogen receptor itself.
What Else Shapes Migraine Frequency and Severity
Sleep irregularity, dehydration, skipped meals, certain food triggers, weather changes, and stress remain some of the most reliable, modifiable factors in migraine frequency, regardless of genetic background. Hormonal fluctuations clearly matter for many women even though the specific genetic mechanism remains unclear. Keeping a headache diary to identify personal patterns often provides more immediately useful information than genetic testing alone, though understanding your broader genetic tendencies can add helpful context.
Where Genetic Testing Fits In
If you’re curious about the biological tendencies behind your own migraines, a headaches and migraines genetic report can walk through markers like these in personalized detail. It’s meant to build understanding, not to replace a neurologist’s evaluation or guide treatment decisions on its own.
Frequently Asked Questions
If migraines run in my family, will I definitely get them too?
Not necessarily. Migraine has a strong genetic component, but it’s polygenic for most people, meaning many small genetic factors combine with environmental triggers rather than one gene determining the outcome.
Is hemiplegic migraine dangerous?
It can involve serious symptoms like temporary paralysis and should always be evaluated by a neurologist, especially on first occurrence, to rule out other causes of stroke-like symptoms.
Does genetic testing show which migraine medication will work for me?
Not currently in a clinically established way for most migraine medications. Treatment decisions are generally based on symptom patterns and response, guided by a neurologist or headache specialist.
